A phase I/II trial of high-dose radioimmunotherapy (RIT) with Zevalin in combination with high-dose etoposide (VP-16) and cyclophosphamide (CY) followed by autologous stem cell transplant (ASCT) in patients with poor-risk or relapsed B-cell non-Hodgkin's lymphoma (NHL).

被引：0
|
作者：
Nademanee, A
Molina, A
Forman, SJ
Kogut, N
Yamauchi, D
An, L
White, CA
Raubitschek, A
机构：
[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[2] Kaiser Permanente City Hope, Bone Marrow Transplant Program, Duarte, CA 91010 USA
[3] Idec Pharmaceut Corp, San Diego, CA USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
679
引用
收藏
页码：182A / 182A
页数：1
相关论文
共 50 条
  • [31] High-dose chemotherapy and autologous stem cell transplant in adolescent patients with relapsed or refractory Hodgkin's lymphoma
    Akhtar, S.
    El Weshi, A.
    Rahal, M.
    Abdelsalam, M.
    Al Husseini, H.
    Maghfoor, I.
    BONE MARROW TRANSPLANTATION, 2010, 45 (03) : 476 - 482
  • [32] High-dose chemotherapy and autologous stem cell transplant in adolescent patients with relapsed or refractory Hodgkin's lymphoma
    S Akhtar
    A El Weshi
    M Rahal
    M Abdelsalam
    H Al Husseini
    I Maghfoor
    Bone Marrow Transplantation, 2010, 45 : 476 - 482
  • [33] A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide: A Novel Preparative Regimen Prior to Autologous Peripheral Blood Stem Cell (PBSC) Transplantation in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma
    Farag, Sherif
    Wood, Lisa L.
    Srivastava, Shivani
    Nelson, Robert P., Jr.
    Schwartz, Jennifer E.
    Cox, Elizabeth
    Abonour, Rafat
    Robertson, Michael
    BLOOD, 2009, 114 (22) : 1321 - 1321
  • [34] Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma
    Kriegsmann, Katharina
    Rieger, Michael
    Schwarzbich, Mark-Alexander
    Sitter, Soeren
    Kriegsmann, Mark
    Bruckner, Thomas
    Hensel, Manfred
    Ho, Anthony Dick
    Witzens-Harig, Mathias
    Wuchter, Patrick
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (01) : 12 - 20
  • [35] High-dose versus standard-dose rituximab with BEAM in autologous stem cell transplantation (SCT) for relapsed aggressive b-cell non-Hodgkin's lymphomas (NHL).
    Srour, Samer Ali
    Khouri, Issa F.
    Nieto, Yago
    Popat, Uday R.
    Qazilbash, Muzaffar H.
    Anderlini, Paolo
    Kebriaei, Partow
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Hosing, Chitra
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] High-dose therapy and autologous stem cell transplantation (ASCT) for poor-risk and relapsed non-Hodgkin's lymphoma (NHL): Long-term follow-up results and analysis of prognostic factors in 369 patients.
    Nademanee, A
    Molina, A
    Dagis, AC
    O'Donnell, MR
    Snyder, DS
    Stein, A
    Parker, PH
    Wong, KK
    Kashyap, A
    Spielberger, RS
    Fung, HC
    Krishnan, A
    Bhatia, R
    Rodriquez, R
    Vora, N
    Sniecinski, I
    Niland, JC
    Forman, SJ
    BLOOD, 1999, 94 (10) : 170A - 170A
  • [37] HIGH-DOSE VERSUS STANDARD-DOSE RITUXIMAB WITH BEAM IN AUTOLOGOUS STEM CELL TRANSPLANTATION (SCT) FOR RELAPSED AGGRESSIVE B-CELL NON-HODGKIN'S LYMPHOMAS (NHL)
    Srour, S. A.
    Lozano, S.
    Nieto, Y.
    Alousi, A. M.
    Popat, U. R.
    Quazilbash, M. H.
    Anderlini, P.
    Kebriaei, P.
    Shpall, E.
    Champlin, R. E.
    Hosing, C.
    HAEMATOLOGICA, 2016, 101 : 114 - 114
  • [38] Phase I Dose-Escalation Study of Venetoclax Plus BEAM Followed By Autologous Stem Cell Transplant (ASCT) for Chemoresistant or High-Risk Relapsed/Refractory Non-Hodgkin Lymphoma (NHL)
    Maakaron, Joseph
    Zhao, Qiuhong
    Puto, Marcin
    Verfurth, Quinn
    Penza, Sam
    Brammer, Jonathan E.
    Efebera, Yvonne A.
    Rosko, Ashley E.
    Saad, Ayman
    Jaglowski, Samantha
    William, Basem M.
    BLOOD, 2019, 134
  • [39] Reduced-dose zevalin™ radioimmunotherapy for relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL) patients with thrombocytopenia:: Report of interim results of a phase II trial.
    Witzig, TE
    White, CA
    Gordon, LI
    Schilder, RJ
    Wiseman, GA
    Rimmer, A
    Parker, E
    Grillo-Lopez, AJ
    BLOOD, 1999, 94 (10) : 92A - 92A
  • [40] HIGH-DOSE CYCLOPHOSPHAMIDE, ETOPOSIDE AND BCNU WITH NON-CRYOPRESERVED AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION FOR POOR PROGNOSIS HODGKIN'S LYMPHOMA
    Brahimi, M.
    Yafour, N.
    Osmani, S.
    Attaf, F.
    Tadj, H.
    Arabi, A.
    Soltan, B. Enta
    Berredouane, H.
    Benzineb, B.
    Bey, M.
    Bahlat, N.
    Bekadja, M. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 655 - 656
12345